Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹86.9 Cr -11.8% -16% -46.7% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,125.4 Cr -1.8% -13.1% 14.8% Stock Analytics
KIRI INDUSTRIES ₹3,234.9 Cr -4.2% -10.4% 40.2% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,690.4 Cr 0.4% -6.8% -28.2% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,273.9 Cr -7.5% -10% 54.9% Stock Analytics
BODAL CHEMICALS ₹768.3 Cr -1.5% -2.7% -18.8% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-11.8%

-16%

-46.7%

SENSEX

-1.4%

3.1%

3.8%


You may also like the below Video Courses